Report Detail
Global Cancer Molecular Biomarkers Market Research Report 2019
- RnM3086597 |
- 09 March, 2019 |
- Global |
- 107 Pages |
- QYResearch |
- Other
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments.
Factors such as technological advancements, increasing research and development activities, increase in funding from various government and non-government organizations, rise in healthcare expenditure, non invasive technology, increasing incidences of cancer, and streamlined drug delivery process are expected to drive the market for cancer molecular biomarkers .In addition, growing survival rates and increased accuracy of diagnosis with the help of biomarkers are expected to drive market for cancer molecular biomarkers.
The global Cancer Molecular Biomarkers market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cancer Molecular Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Molecular Biomarkers market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Correlogic Systems
AgendiaBv
BioMerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix
Clarient
Biomoda
Beckman Coulter
Dickinson
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Genetic Methods
Protein Methods
Imaging
Segment by Application
Pharmaceutical Companies
Medical Laboratory
Hospital
Table of Contents
Executive Summary
1 Cancer Molecular Biomarkers Market Overview
- 1.1 Product Overview and Scope of Cancer Molecular Biomarkers
- 1.2 Cancer Molecular Biomarkers Segment by Type
- 1.2.1 Global Cancer Molecular Biomarkers Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Genetic Methods
- 1.2.3 Protein Methods
- 1.2.4 Imaging
- 1.3 Cancer Molecular Biomarkers Segment by Application
- 1.3.1 Cancer Molecular Biomarkers Consumption Comparison by Application (2014-2025)
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Medical Laboratory
- 1.3.4 Hospital
- 1.4 Global Cancer Molecular Biomarkers Market by Region
- 1.4.1 Global Cancer Molecular Biomarkers Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Cancer Molecular Biomarkers Market Size
- 1.5.1 Global Cancer Molecular Biomarkers Revenue (2014-2025)
- 1.5.2 Global Cancer Molecular Biomarkers Production (2014-2025)
2 Global Cancer Molecular Biomarkers Market Competition by Manufacturers
- 2.1 Global Cancer Molecular Biomarkers Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Cancer Molecular Biomarkers Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Cancer Molecular Biomarkers Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Cancer Molecular Biomarkers Production Sites, Area Served, Product Types
- 2.5 Cancer Molecular Biomarkers Market Competitive Situation and Trends
- 2.5.1 Cancer Molecular Biomarkers Market Concentration Rate
- 2.5.2 Cancer Molecular Biomarkers Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Cancer Molecular Biomarkers Production Market Share by Regions
- 3.1 Global Cancer Molecular Biomarkers Production Market Share by Regions
- 3.2 Global Cancer Molecular Biomarkers Revenue Market Share by Regions (2014-2019)
- 3.3 Global Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Cancer Molecular Biomarkers Production
- 3.4.1 North America Cancer Molecular Biomarkers Production Growth Rate (2014-2019)
- 3.4.2 North America Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Cancer Molecular Biomarkers Production
- 3.5.1 Europe Cancer Molecular Biomarkers Production Growth Rate (2014-2019)
- 3.5.2 Europe Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Cancer Molecular Biomarkers Production (2014-2019)
- 3.6.1 China Cancer Molecular Biomarkers Production Growth Rate (2014-2019)
- 3.6.2 China Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Cancer Molecular Biomarkers Production (2014-2019)
- 3.7.1 Japan Cancer Molecular Biomarkers Production Growth Rate (2014-2019)
- 3.7.2 Japan Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Cancer Molecular Biomarkers Consumption by Regions
- 4.1 Global Cancer Molecular Biomarkers Consumption by Regions
- 4.2 North America Cancer Molecular Biomarkers Consumption (2014-2019)
- 4.3 Europe Cancer Molecular Biomarkers Consumption (2014-2019)
- 4.4 China Cancer Molecular Biomarkers Consumption (2014-2019)
- 4.5 Japan Cancer Molecular Biomarkers Consumption (2014-2019)
5 Global Cancer Molecular Biomarkers Production, Revenue, Price Trend by Type
- 5.1 Global Cancer Molecular Biomarkers Production Market Share by Type (2014-2019)
- 5.2 Global Cancer Molecular Biomarkers Revenue Market Share by Type (2014-2019)
- 5.3 Global Cancer Molecular Biomarkers Price by Type (2014-2019)
- 5.4 Global Cancer Molecular Biomarkers Production Growth by Type (2014-2019)
6 Global Cancer Molecular Biomarkers Market Analysis by Applications
- 6.1 Global Cancer Molecular Biomarkers Consumption Market Share by Application (2014-2019)
- 6.2 Global Cancer Molecular Biomarkers Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Cancer Molecular Biomarkers Business
- 7.1 Correlogic Systems
- 7.1.1 Correlogic Systems Cancer Molecular Biomarkers Production Sites and Area Served
- 7.1.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.1.3 Correlogic Systems Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 AgendiaBv
- 7.2.1 AgendiaBv Cancer Molecular Biomarkers Production Sites and Area Served
- 7.2.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.2.3 AgendiaBv Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 BioMerieux
- 7.3.1 BioMerieux Cancer Molecular Biomarkers Production Sites and Area Served
- 7.3.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.3.3 BioMerieux Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Aureon Laboratories
- 7.4.1 Aureon Laboratories Cancer Molecular Biomarkers Production Sites and Area Served
- 7.4.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.4.3 Aureon Laboratories Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Astellas Pharma US
- 7.5.1 Astellas Pharma US Cancer Molecular Biomarkers Production Sites and Area Served
- 7.5.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.5.3 Astellas Pharma US Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Becton
- 7.6.1 Becton Cancer Molecular Biomarkers Production Sites and Area Served
- 7.6.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.6.3 Becton Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Diadexus
- 7.7.1 Diadexus Cancer Molecular Biomarkers Production Sites and Area Served
- 7.7.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.7.3 Diadexus Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Abbott Laboratories
- 7.8.1 Abbott Laboratories Cancer Molecular Biomarkers Production Sites and Area Served
- 7.8.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.8.3 Abbott Laboratories Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Affymetrix
- 7.9.1 Affymetrix Cancer Molecular Biomarkers Production Sites and Area Served
- 7.9.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.9.3 Affymetrix Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Clarient
- 7.10.1 Clarient Cancer Molecular Biomarkers Production Sites and Area Served
- 7.10.2 Cancer Molecular Biomarkers Product Introduction, Application and Specification
- 7.10.3 Clarient Cancer Molecular Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 Biomoda
- 7.12 Beckman Coulter
- 7.13 Dickinson
8 Cancer Molecular Biomarkers Manufacturing Cost Analysis
- 8.1 Cancer Molecular Biomarkers Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Cancer Molecular Biomarkers
- 8.4 Cancer Molecular Biomarkers Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Cancer Molecular Biomarkers Distributors List
- 9.3 Cancer Molecular Biomarkers Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Cancer Molecular Biomarkers Market Forecast
- 11.1 Global Cancer Molecular Biomarkers Production, Revenue Forecast
- 11.1.1 Global Cancer Molecular Biomarkers Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Cancer Molecular Biomarkers Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Cancer Molecular Biomarkers Price and Trend Forecast (2019-2025)
- 11.2 Global Cancer Molecular Biomarkers Production Forecast by Regions (2019-2025)
- 11.2.1 North America Cancer Molecular Biomarkers Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Cancer Molecular Biomarkers Production, Revenue Forecast (2019-2025)
- 11.2.3 China Cancer Molecular Biomarkers Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Cancer Molecular Biomarkers Production, Revenue Forecast (2019-2025)
- 11.3 Global Cancer Molecular Biomarkers Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Cancer Molecular Biomarkers Consumption Forecast (2019-2025)
- 11.3.2 Europe Cancer Molecular Biomarkers Consumption Forecast (2019-2025)
- 11.3.3 China Cancer Molecular Biomarkers Consumption Forecast (2019-2025)
- 11.3.4 Japan Cancer Molecular Biomarkers Consumption Forecast (2019-2025)
- 11.4 Global Cancer Molecular Biomarkers Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Cancer Molecular Biomarkers Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Cancer Molecular Biomarkers. Industry analysis & Market Report on Cancer Molecular Biomarkers is a syndicated market report, published as Global Cancer Molecular Biomarkers Market Research Report 2019. It is complete Research Study and Industry Analysis of Cancer Molecular Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
